UPDATE : Monday, September 7, 2020
Korean Covid-19 vaccine, treatment candidates effective in monkeys
Genexine’s investigational Covid-19 vaccine and Celltrion’s treatment candi...
by Kim Chan-hyuk  |  2020-08-20 13:45
Hanmi to present study on fatty liver drugs in Europe
Hanmi Pharmaceutical said Tuesday that the company would present its recent...
by Shim Hyun-tai  |  2020-08-19 16:13
Jaytech Biogen punished for omitting report of sex hormone drugs supply
The Ministry of Food and Drug Safety said it has imposed an administrative ...
by Kim Chan-hyuk  |  2020-08-19 15:15
Bridge Bio shares plummet on possible cancellation of ₩1.5-trillion deal
Bridge Biotherapeutics shares tanked on Wednesday, as the company did not r...
by Lee Han-soo  |  2020-08-19 13:07
Philosys’ sample collection kit wins FDA nod
Philosys, an affiliate of Philosys Healthcare, said Tuesday that it has won...
by Shim Hyun-tai  |  2020-08-18 18:21
LG Chem licenses in NASH treatment candidate from China
LG Chem said that it has licensed in TT-01025, a non-alcoholic steatohepati...
by Lee Han-soo  |  2020-08-18 15:18
Medytox shares resurge as court allows sales resumption of Meditoxin
Medytox's shares hit its upper limits on Tuesday, as a local court acce...
by Lee Han-soo  |  2020-08-18 15:18
GC Labcell confirms efficacy of NK cell therapy in treating Covid-19
GC Labcell said that it has confirmed the efficacy of its natural killer (N...
by Lee Han-soo  |  2020-08-18 15:10
MSD Korea’s spinoff Organon Korea to settle in Gwanghwamun
Organon Korea, a spinoff from MSD Korea, will use a shared office in Gwangh...
by Kim Yun-mi  |  2020-08-18 11:39
SK Bioscience inks CDMO deal with Novavax for Covid-19 vaccine
SK Bioscience, a subsidiary of SK Chemical, has signed a CDMO (contract dev...
by Lee Han-soo  |  2020-08-14 15:36
Covid-19 makes Vivozon halt P3 trial of nonnarcotic analgesics in US
said that it has halted its phase 3b clinical trials for using opiranserin,...
by Lee Han-soo  |  2020-08-13 17:27
Takeda expects more effective IBD treatment with Kynteles' expanded reimbursement
Takeda Korea is strengthening its position in the domestic inflammatory bow...
by Lee Han-soo  |  2020-08-12 17:45
Roche’s Tecentriq-Avastin combo wins nod to treat hepatocellular carcinoma
Roche has become the first company in Korea to win the regulator’s nod to u...
by Lee Han-soo  |  2020-08-12 14:35
Daewoong to conduct P1 trial of Covid-19 treatment in India
Daewoong Pharmaceutical said that the Indian health regulators have approve...
by Lee Han-soo  |  2020-08-11 17:48
Curocell draws $37-million investment, steps up trials of CAR-T therapy
Curocell, Korea’s first developer of chimeric antigen receptor T (CAR-T) ce...
by Park Gi-taek  |  2020-08-10 17:28
Rheumatoid arthritis drug Rinvoq gets insurance benefit
AbbVie Korea’s rheumatoid arthritis treatment Rinvoq SR Tab. 15mg (ingredie...
by Kim Eun-young  |  2020-08-07 14:34
Regulator OKs Pfizer's BRCA mutation breast cancer treatment
Pfizer Korea said that the Ministry of Food and Drug Safety has approved Ta...
by Lee Han-soo  |  2020-08-05 16:02
Hanmi, MSD sign licensing agreement for hepatitis treatment
Hanmi Pharmaceutical said it has entered into an exclusive licensing agreem...
by Shim Hyun-tai  |  2020-08-05 15:24
Korean biopharmaceutical market expands on biosimilar export growth
The domestic biopharmaceutical market grew last year, mainly boosted by exp...
by Kim Chan-hyuk  |  2020-08-04 15:46
Medpacto to unveil trial results at European conference
Medpacto, a biomarker-based new drug developer, said it would present the p...
by Lee Han-soo  |  2020-08-04 14:44
Back to Top